Health and Healthcare

Amgen : AMGN

All Amgen Articles

699 Articles

Chris Lange | Nov 10, 2016 at 7:20 AM EST

Short Sellers Grow More Selective on Major Biotechs

Now that the U.S. presidential election is over and Hillary Clinton is out of the picture, major biotech companies can…

Chris Lange | Oct 29, 2016 at 9:45 AM EDT

6 Companies That Destroyed Shareholders Last Week

The broad markets are holding steady near their double bottom set this summer. However, over the course of the past…

Chris Lange | Oct 28, 2016 at 9:10 AM EDT

Amgen Sinks Despite Beating Street Estimates

Though Amgen reported better-than-expected third-quarter results on Thursday, shares sank early Friday.

Chris Lange | Oct 27, 2016 at 12:40 PM EDT

What to Watch When Amgen Reports Earnings

Biotech giant Amgen is scheduled to release its third-quarter financial results after the markets close on Thursday.

Chris Lange | Oct 26, 2016 at 7:15 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The October 14 short interest data have been compared with the previous report, and short interest moves in these selected…

Chris Lange | Oct 23, 2016 at 10:35 AM EDT

Top Health Care Earnings Coming Next Week

Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of…

Jon C. Ogg | Oct 20, 2016 at 12:25 PM EDT

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

Americans generally would like to spend less money on health care. One way that this can be and will be…

Lee Jackson | Oct 20, 2016 at 9:55 AM EDT

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

These top biotech companies have been absolutely hammered and now trade at a valuation much lower than large cap pharmaceuticals.

Chris Lange | Oct 12, 2016 at 7:10 AM EDT

Short Sellers Have Mixed Views on Major Biotechs

If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a…

Chris Lange | Sep 27, 2016 at 7:50 AM EDT

Short Sellers Increase Bets in Major Biotechs

The September 15 short interest data have been compared with the previous report, and short interest moves were upward across…

Jon C. Ogg | Sep 26, 2016 at 8:15 AM EDT

How Much Will Consumers Save on New Humira Biosimilar?

In a time when government wrangling about drug prices is more than commonplace, news of a biosimilar for the mega-blockbuster…

Lee Jackson | Sep 19, 2016 at 8:25 AM EDT

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

An RBC report noted that although headline issues such as the Federal Reserve and the election are increasing volatility, four…

Chris Lange | Sep 13, 2016 at 7:05 AM EDT

Short Sellers Run for Cover From Major Biotechs

The August 31 short interest data have been compared with the previous report, and short interest decreased for most of…

Chris Lange | Aug 25, 2016 at 8:40 AM EDT

Short Sellers Increase Bets in Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across…

Chris Lange | Aug 10, 2016 at 8:50 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the July 29 settlement date and short interest decreased across these selected biotech…

1 … 20 21 22 23 24 … 47

Amgen : AMGN

All Amgen Articles

Short Sellers Grow More Selective on Major Biotechs

6 Companies That Destroyed Shareholders Last Week

Amgen Sinks Despite Beating Street Estimates

What to Watch When Amgen Reports Earnings

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Health Care Earnings Coming Next Week

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

Short Sellers Have Mixed Views on Major Biotechs

Short Sellers Increase Bets in Major Biotechs

How Much Will Consumers Save on New Humira Biosimilar?

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

Short Sellers Run for Cover From Major Biotechs

Short Sellers Increase Bets in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

Amgen : AMGN

All Amgen Articles

Short Sellers Grow More Selective on Major Biotechs

6 Companies That Destroyed Shareholders Last Week

Amgen Sinks Despite Beating Street Estimates

What to Watch When Amgen Reports Earnings

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Health Care Earnings Coming Next Week

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

Short Sellers Have Mixed Views on Major Biotechs

Short Sellers Increase Bets in Major Biotechs

How Much Will Consumers Save on New Humira Biosimilar?

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

Short Sellers Run for Cover From Major Biotechs

Short Sellers Increase Bets in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%